Sophisticated AI analysis reveals efficacy of neuroprotective drug for severe stroke
New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective...
Continue reading
Latest news
Read the Perron Institute’s media statements here. See some of the Perron Institute’s media coverage here. Watch our videos on the Perron Institute YouTube channel.
Vale Emeritus Professor Bryant Stokes AO
With deep respect and gratitude, the Perron Institute acknowledges the death of Emeritus Professor Bryant Stokes AO, a revered neurosurgeon whose outstanding contributions have had a massive impact on medical...
Continue reading
Demystifying the Compassionate Communities approach to caring, dying and grieving
Building community capacity in end-of-life care and dispelling misconceptions are themes of a recently published editorial in the journal Palliative Care and Social Practice. Co-author...
Continue reading
Honouring the innovative, creative Professor Minghao Zheng AM
The Member of the Order of Australia (AM) honour awarded to Professor Minghao Zheng AM for advancement of regenerative medicine...
Continue reading
Major funding for WA project on treatment of youth depression
Developing a personalised prescribing model to improve treatment for depression and anxiety is the aim of a leading-edge mental health...
Continue reading
Professor Samar Aoun AM awarded MNDAWA Life Membership
The Motor Neurone Disease Association of Western Australia (MNDAWA) Life Membership is awarded in recognition for providing extraordinary service to the Association over a period...
Continue reading
Perron Institute Board appointments announced
Western Australia’s Perron Institute has recently appointed two non-Executive Directors, each with an impressive record of achievement in their fields of expertise. Paul Anderson has 25 years’ experience in...
Continue reading
Innovative WA research on dystonia attracts “near miss” grant
Research on genetic causes of dystonia in Australian families affected by this severely disabling neurological movement disorder has received support under the 2025-26 WA Government’s Future...
Continue reading
WA researchers highlight advances in precision approach for treating MND
The rapidly evolving field of precision medicine and how it is reshaping the understanding and treatment of motor neurone disease (MND) is explored in a recent review led by researchers in Western Australia as...
Continue reading
Tailoring antidepressant treatment in young Australians
The protocol of an Australian-first pilot study based at the Perron Institute in Western Australia which explores the efficacy of personalised antidepressants in young people with major depressive disorder (MDD) has been published. ...
Continue reading
Symposium of Western Australian Neuroscience (SWAN) 2025
The Symposium of Western Australian Neuroscience (SWAN) recently brought together researchers, clinicians, and students for a full day of sharing...
Continue reading
Professor Minghao Zheng elected AAHMS Fellow
Professor Minghao Zheng, head of Bone and Brain Research at the Perron Institute and The University of Western Australia has...
Continue reading